SCHEMBL6423997

SCHEMBL6423997

Cc1c([C@](C)(C(=O)O)C2CCCC2)c2cc(O)c(F)cc2n1C(=O)c1ccc(F)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MGLL Q99685 4/20 0.33
FAAH O00519 2/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
PDE2A O00408 1/20 0.33
GRM5 P41594 1/20 0.32
AKR1C3 P42330 2/20 0.32
AKR1C2 P52895 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SRC P12931 3/20 0.31
PRKACA P17612 2/20 0.31
PRKACG P22612 2/20 0.31
PRKACB P22694 2/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6425919 0.98 HSD11B1 (0.35) HSD11B1MEN1KMT2AMGLLFAAH
SCHEMBL6464934 0.92 PDE2A (0.35) HSD11B1MGLLFAAHPDE2AAKR1C3
SCHEMBL6423924 0.92 AKR1C3 (0.41) MEN1KMT2AMGLLAKR1C3AKR1C2
SCHEMBL6453005 0.90 PDE2A (0.35) MGLLFAAHPDE2AAKR1C3AKR1C2
SCHEMBL6424976 0.90 HSD11B1 (0.36) HSD11B1MGLLFAAHTAS1R3TAS1R2
SCHEMBL6425630 0.90 AKR1C3 (0.41) MEN1KMT2AMGLLAKR1C3AKR1C2
SCHEMBL6423665 0.89 ALDH1A1 (0.37) HSD11B1MEN1KMT2AMGLLAKR1C3
SCHEMBL6424870 0.89 TDP1 (0.38) HSD11B1MEN1KMT2AMGLLGRM5
SCHEMBL6424954 0.89 PTGS2 (0.42) HSD11B1MEN1KMT2AMGLLTAS1R3
SCHEMBL6424784 0.88 HSD11B1 (0.36) HSD11B1MGLLFAAHAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 HSD11B1 1120/4885MEN1 3824/4885KMT2A 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.